Related by context. All words. (Click for frequent words.) 70 AKIP ™ 66 ArQule Kinase Inhibitor Platform 64 ArQule Kinase Inhibitor 61 protein kinase inhibitor 60 selective inhibitors 60 small molecule modulators 60 Epothilones 60 reversible inhibitor 59 kinase inhibitors 59 therapeutic monoclonal antibodies 59 small molecule inhibitors 59 ATP adenosine triphosphate 59 histone methyltransferases HMTs 58 FGFR 58 Ibis T# TM 58 novel peptide 58 product platforms AZX# 58 proprietary LNA 58 immunotherapeutics 58 Adnectin 57 polymerase inhibitors 57 small molecule 57 highly selective inhibitor 57 biased ligand 57 small molecule agonists 57 commercializing anti infective 57 5 HT2A inverse 57 selective kinase inhibitor 57 MEK inhibitors 57 blood serum biomarkers 57 single stranded oligonucleotides 57 OTCBB PYTO 57 mitogen activated ERK kinase 57 anticancer therapeutics 57 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 56 ZFPs 56 PDE4 inhibitor 56 rxRNA 56 5 HT6 receptor 56 HepDirect R 56 Vaccinex 56 small molecule defensin 56 DNAi 56 novel immunomodulatory 56 gastro intestinal inflammation 56 Receptors GPCRs 56 XmAb ™ 56 prodrugs 56 orally administered inhibitor 56 biologic therapeutics 56 XL# XL# 56 antisense drugs 56 Nanobody ® 56 anticancer compounds 56 MEK inhibitor 56 HCV NS3 protease 56 mitotic kinesins 56 pralatrexate injection folate analogue 56 humanized monoclonal antibodies 55 epothilones 55 novel orally administered 55 G Protein Coupled 55 Locked Nucleic Acid 55 PNP inhibitor 55 Board LWLG technology 55 epothilone 55 anionic backbone 55 sigma receptors 55 orally bioavailable 55 sodium glucose cotransporter 55 selective immunoproteasome inhibitor 55 ENMD # 55 NuMimetic TM 55 synthetic cannabinoid compounds 55 vascular disrupting agents 55 optical biosensors 55 SARMs 55 agonist compounds 55 Nasdaq HALO biopharmaceutical 55 JAK2 inhibitor 55 selective androgen receptor modulators 55 small molecule activators 55 NASDAQ SNTA biopharmaceutical 55 recombinant polyclonal antibodies 55 AAG geldanamycin analog 55 Maxy G# 55 preclinical compounds 55 small molecule inhibitor 55 Monoclonal antibodies 54 siRNA compounds 54 Anticalin 54 theranostic 54 KSP inhibitor 54 affinity ligands 54 Solazed TM 54 small molecule therapeutics 54 novel RNAi therapeutics 54 multi kinase inhibitor 54 Nasdaq XTLB 54 investigational humanized monoclonal antibody 54 specific lectin receptors 54 Alfacell proprietary ribonuclease 54 therapeutic monoclonal antibody 54 peptidomimetic 54 Sphingomab 54 factor receptor FGFR 54 antimitotic 54 Locked Nucleic Acid LNA 54 proteasome inhibitor 54 CCR9 antagonist 54 FOLOTYN ® 54 rxRNA compounds 54 BCR ABL inhibitors 54 ETBs 54 HSP# inhibitor 54 ANGPTL4 54 epigenetic enzymes 54 Alzheimer disease cognitive impairment 54 CYT# potent vascular disrupting 54 monoclonal antibody therapeutics 54 MPH AMEX 54 histone deacetylase HDAC 54 NovaBay Aganocide compounds 54 cancer immunotherapies 54 selective inverse agonist 54 microRNA therapeutics 54 Hsp# inhibition 54 Viprovex R 54 TLR9 agonist 54 isoform selective 54 Notch receptors 54 small molecule tyrosine 54 PDE# 54 #/#/# Cytokinetics Incorporated 54 GPCR targets 53 DOS# 53 taste modulators 53 THR beta agonist 53 Nasdaq LXRX biopharmaceutical 53 ErbB3 HER3 53 brain penetrant 53 selective inhibition 53 NYSE Amex PTN 53 Nasdaq MITI biopharmaceutical 53 rxRNA ™ compounds 53 cyclin dependent kinase inhibitor 53 diagnostic biomarkers 53 Hybridon 53 Nasdaq ENZN 53 infectious diseases autoimmune 53 nitric oxide donating 53 potent inhibitors 53 IXSBF 53 therapeutic antibodies 53 JAK1 53 Viprovex TM 53 mGluR4 53 immune modulators 53 commercialize Aganocides 53 lipid nanoparticles 53 novel antibody therapeutics 53 polyketides 53 Maribavir 53 OMP #M# 53 biologically validated targets 53 peptide peptide mimetic 53 synthetic peptides 53 Pentad TM 53 RNA antagonist 53 Selective Electrochemical Tumor Ablation 53 CYT# novel 53 clinically validated targets 53 Exelixis compounds 53 neuroprotective properties 53 delta isoform 53 TLR7 53 subsidiaries InnerCool Therapies 53 M2 subunit 53 CORT # 53 HuLuc# 53 CD# CEA 53 Nanobodies 53 proteasome inhibitors 53 autoimmune inflammatory 53 targeting CD# 53 Personalized Immunotherapy 53 engineered proteases 53 aptamer therapeutics 53 BRAF kinase 53 OTCBB HXBM developer 53 derivatives Radilex TM 53 Dyax phage display 53 JAK3 53 proprietary PEGylation 53 purinergic receptors P#X# 53 hypoxia activated prodrug 53 investigational pan BCR 53 AEG# 53 inhibit KSP 53 immunotherapies 53 pathophysiological effects 53 AMPK activators 52 TLR9 52 SAR# [002] 52 stable nucleic acid 52 reversible inhibitors 52 CCX# 52 acne impetigo 52 dAbs 52 Nasdaq RGDX 52 Preclinical studies suggest 52 MAbs targeting 52 NEUGENE antisense 52 Anticalins R 52 novel anti infective 52 selective antagonist 52 Carfilzomib 52 peptidic compound 52 TLR8 52 Protein Kinase C 52 Dicer Substrate Technology 52 cytoskeleton enables 52 oral prodrug 52 VEGF receptors 52 mda 7 52 Cylene 52 Cellgate Inc. 52 ADP receptor antagonist 52 Brussels THR 52 www.ucb group.com 52 rusalatide acetate 52 kinase inhibition 52 siRNA therapeutics 52 antisense inhibitors 52 novel peptides 52 coupled receptor GPCR 52 inhaled formulation 52 peptide antigens 52 diagnostic molecular imaging 52 candidate deforolimus 52 candidates Azedra TM 52 Corporation Nasdaq CRGN 52 kinase inhibitor 52 Delta opioid receptor 52 humanized antibodies 52 LEX System 52 Inc. Nasdaq IMGN 52 Fleximer 52 biased ligands 52 synthetic retinoid 52 HDAC inhibitor 52 Chronogen 52 investigational therapies 52 SNALP technology 52 protein kinase inhibitors 52 oncolytic 52 predictive biomarkers 52 molecular biomarkers 52 Tumour Vascular Disrupting Agent 52 IAP inhibitor 52 JAK#/JAK# 52 Oracea TM 52 developing Zerenex TM 52 tiapamil 52 tubulin inhibitors 52 CRMD pharmaceutical 52 Aganocide ® 52 5 HT2A serotonin 52 potent inhibitor 52 JAK inhibitor 52 Nasdaq MYRX 52 OTC Bulletin Board LWLG 52 liposomal formulation 52 humanised antibody 52 Smac mimetics 52 antiangiogenesis therapies 52 OTCBB PYTO FWB ET6 52 ALN TTR 52 histone deacetylase inhibitor 52 Homspera TM 52 targeted immunotherapies 52 oncology therapeutics 52 5 HT4 receptor 52 humanized anti 52 selective inhibitor 52 adrenergic regulation 52 novel immunotherapies 51 Liposomal 51 hormone LHRH antagonist 51 immunotherapeutic 51 vaccine GRNVAC1 51 kidney urologic 51 NEUGENE 51 aluminosilicate clay 51 ImmuneRegen BioSciences Inc. 51 adenosine A2A 51 defensin mimetic antibiotic 51 XmAb TM 51 oral ghrelin agonist 51 muscarinic receptor agonist 51 AMEX REX 51 NASDAQ EPIX biopharmaceutical 51 2 methoxyestradiol 51 Helix BioMedix Inc. 51 Ligand proprietary 51 IAP inhibitors 51 HCV protease 51 bioactive lipids 51 Company Nasdaq RGDX 51 HepDirect 51 novel orally bioavailable 51 novel therapeutic antibodies 51 neuronal nicotinic receptors NNRs 51 XmAb 51 potently inhibit 51 OTCBB CHKT biotechnology 51 lipid particles SNALP 51 HCV polymerase inhibitors 51 Isis antisense 51 peptibody 51 Nanobody 51 molecular imaging radiopharmaceuticals 51 compound PMX # 51 accumulate preferentially 51 PSN# [002] 51 generation antisense 51 siRNA therapeutic 51 PTP 1B 51 Squalamine 51 DURECT proprietary 51 XmAb ® 51 histone deacetylase HDAC inhibitors 51 Hsp# inhibitors 51 Nasdaq PARD 51 RNAi therapeutic targeting 51 antiviral compounds 51 Archexin 51 Aurora kinase inhibitor 51 commercializing therapeutic 51 anticoagulant reversing agent 51 BN# [002] 51 ALN PCS 51 OTCQB CTIX 51 CYC# 51 Curaxins 51 AB OMXS BINV 51 Anticalins ® 51 Fc fusion protein 51 IMiDs R 51 RNA therapeutics 51 polymerase inhibitor 51 CCR1 51 MyVax R 51 DiLA2 platform 51 PROfusion 51 molecular imaging radiopharmaceutical 51 PDE# inhibitors 51 Neurogen Corporation 51 MDRNA proprietary 51 Novosom 51 oncolytic viruses 51 Nasdaq PARD biopharmaceutical 51 small molecule glucokinase 51 PORxin TM 51 NEUGENE R 51 Nucleic acids 51 peptide therapeutics 51 Sphingomab TM 51 JAK2 kinase 51 PI3K/mTOR 51 sulfonylhydrazine class 51 topically delivered 51 neuro inflammatory 51 Accelerated Intelligent 51 AvalonRx ® 51 ELADUR ™ 51 OTCBB QTXB 51 Myolimus 51 small molecule thrombopoietin 51 inhibitor PPI 51 monoclonal antibodies 51 dermatology therapies 51 immunological diseases 51 novel antiviral therapeutics 51 GMX# 51 IMiDs 51 novel therapeutics 51 anticancer therapies 51 Genesis Biopharma Inc. 51 Phylomer ® 51 HepDirect prodrug 51 c MET 51 hepatitis C polymerase 51 potently inhibited 51 Ostabolin C TM 51 psoriasis rheumatoid arthritis 51 SGLT inhibitors 50 integrative pharmacology 50 P#X# antagonist 50 ribonucleotide reductase clinically validated 50 UsiRNAs 50 NYSE Amex PBTH 50 pan HDAC inhibitor 50 DNA methylation biomarkers 50 VitiGam 50 intracellular signaling pathways 50 NexACT 50 myelofibrosis polycythemia vera 50 recombinant antibodies 50 TSX CTI 50 NNR Therapeutics 50 DsiRNA 50 PI3 kinase 50 anti amnesic 50 Announces Poster Presentations 50 chemogenomics 50 MTP inhibitor 50 SERMs 50 CB2 selective receptor agonist 50 cyclophilin inhibitor 50 intranasal formulation 50 selective androgen receptor modulator 50 adenosine receptor 50 anticancer agents 50 Inc. NASDAQ AEZS 50 Vidofludimus 50 AKT inhibitor 50 Inc. OTCBB IRBS 50 nicotinic alpha 7 50 Guanilib 50 Tyrima 50 LNP formulations 50 poly ADP ribose polymerase 50 Therapeutic antibodies 50 Fibroblast Growth Factor Receptor 50 molecular chaperone regulation 50 chemically modified siRNA 50 tubulin binding 50 preclinically 50 mitotic kinesin 50 cyclin dependent kinases 50 selective angiogenic kinase inhibitor 50 enhance ApoA 50 Avian Transgenic Technology 50 PEGylation technology 50 U1 Adaptors 50 CB2 receptor 50 A3 adenosine receptor 50 PORxin 50 RNAi therapeutic 50 Anticalin R 50 ghrelin antagonist 50 retinoic acid receptor 50 antibody therapeutics 50 eligen R technology 50 Syndax Pharmaceuticals Inc. 50 adrenal steroid hormones 50 Initiates Phase II 50 reformulates existing FDA 50 SMARTICLES ® 50 c Raf kinase 50 polymer conjugate technology 50 biotherapeutics 50 antiviral therapeutics 50 protein tyrosine phosphatase 1B 50 enzyme inhibitors 50 immunotherapeutic approaches 50 anti CD3 50 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 50 KL4 surfactant 50 telomerase inhibitor 50 5 HT4 50 ATL# [002] 50 TLR8 agonist 50 Corp. Nasdaq BSTC 50 siRNAs targeting 50 anti infective treatments 50 predictive toxicology 50 targeted radiotherapeutic 50 BiTE 50 Nasdaq HALO 50 BiTE antibody 50 biomarker discovery 50 metaglidasen 50 Inc. AMEX YMI 50 HDACi 50 HCV protease inhibitor 50 GPR# agonist 50 CD# expressing 50 platform HDL Mimetic 50 renin inhibition promising 50 imatinib Gleevec ® 50 Transcription factors 50 drugable targets 50 MT#/MEDI-# 50 phage display 50 non nucleoside inhibitor 50 PI3K/Akt pathway inhibitor 50 ErbB3 50 MediVas 50 Angiocept 50 GPR# agonists 50 optimized siRNA 50 receptors PPARs 50 Nasdaq TARG 50 allosteric modulator 50 novel anticancer 50 rheumatoid arthritis multiple sclerosis 50 aptamers 50 RECOTHROM R 50 Hypoxia Inducible Factor 50 OGeS 50 prostanoid 50 synthetic siRNA 50 Inc. Nasdaq VIAP 50 ophthalmic diseases 50 investigational monoclonal antibody 50 small molecule activator 50 liposome encapsulated 50 antisense drug 50 CB2 selective 50 Like Receptor 50 allosteric modulators 50 Nanobodies R 50 Cyclooxygenase Inhibiting Nitric Oxide 50 novel histone deacetylase 50 commercializing novel biotherapeutics 50 AtuRNAi 50 mimetics 50 Regado 50 Nasdaq IDRA 50 Listeria vaccine 50 prostacyclins 50 TLR Therapeutics 50 Janus kinase 50 BCR ABL 50 catalytic antioxidant compounds 50 non nucleoside HCV 50 allosteric 50 OXIGON TM 50 OTCBB FCSC biotechnology 50 molecularly targeted 50 Therapeutic Competitors Companies 49 NasdaqGM SPPI commercial 49 cancer therapeutics 49 glucocorticoid receptors 49 TLR antagonists 49 prostones 49 GlycoPEGylated hemostasis compounds 49 proteins peptides 49 phosphate S1P 49 receptor agonists 49 IMiDs ® 49 DiLA2 49 succinic 49 vaccines oncolytic virus 49 advancing novel biotherapeutics 49 Nasdaq RXII 49 ARRY # 49 orally dosed 49 Fleximer R 49 therapeutic antibody 49 pharmacological chaperone 49 recombinant vaccines 49 OTCBB NRGX 49 HDACs 49 TRAIL receptor 49 Morria Biopharmaceuticals Plc 49 NexGenix 49 vascular disrupting agent 49 Voreloxin 49 autoimmune indications 49 oxazolidinone 49 CDK inhibitors 49 antisense oligonucleotides 49 TLR9 agonists 49 Anticalin ® 49 sodium glucose transporter 49 liposomal delivery 49 Factor VIIa 49 Celator 49 Pancreate 49 glucagon receptor 49 romazarit 49 protein therapeutics 49 TSX VIR 49 Talabostat 49 5 HT2A receptor 49 RAF kinase 49 PRNewswire FirstCall Nastech Pharmaceutical 49 innovative signaling pathway 49 sphingosine 1 49 NASDAQ SNTA 49 4SC AG ISIN DE# 49 BHT DNA 49 transfection reagents 49 OTCBB IMNR 49 modified glutathione analog 49 #HT# 49 Dimethyl ether DME 49 chemotherapeutics 49 DPX Survivac 49 mertansine 49 TSX VENTURE DMA 49 triggers apoptosis programmed 49 anti secretory 49 Sangamo ZFP technology 49 prostone 49 Inc. NASDAQ CRIS 49 identify protein biomarkers 49 PRNewswire FirstCall Neurogen 49 Intermezzo ® zolpidem tartrate 49 mGluR2 NAM 49 Umbilical cord stem cells 49 SCYNEXIS 49 generation purine nucleoside 49 Pertuzumab 49 CTLA4 Ig 49 oral ferric iron 49 HDAC enzymes 49 Nasdaq FOLD 49 targeted anticancer biopharmaceuticals 49 ELND-#/AZD-# 49 Tumor Necrosis Factor 49 Hsp# inhibitor 49 Onalta 49 vinca alkaloid 49 intranasal insulin product 49 coupled receptors GPCRs 49 partial agonist 49 fusion proteins 49 Symadex 49 therapeutics 49 validating biomarkers 49 Tarvacin TM 49 carbohydrate polymer 49 Genedata Expressionist ® 49 bio therapeutics 49 Nasdaq IDIX biopharmaceutical 49 Nasdaq OMER 49 NASDAQ AVEO biopharmaceutical 49 p# inhibitors 49 CYP #C# 49 Nanobodies ® 49 endogenous ligands 49 Small Molecule 49 P#X# 49 monocytogenes Listeria vaccines 49 Sapacitabine 49 anticancer compound 49 commercializes therapeutics 49 RONDEL ™ 49 p# inhibitor 49 Cannabinor 49 GSK3B 49 therapeutic peptide 49 targeting PCSK9 49 PI3K inhibitor 49 Panzem 49 Receptos 49 Isogenica 49 infectious diseases autoimmune diseases 49 ASONEP TM 49 Daclizumab 49 PROT biotechnology 49 Aurora kinase 49 AMPAKINE 49 QuantRx Biomedical Corporation 49 OTCBB CGXP 49 synthetic peptide 49 Curaxin CBLC# 49 insulin sensitizer 49 Tarmogen 49 Hana Biosciences 49 pharmacogenetic test 49 GPCRs 49 Cellzome 48 nicotinic acetylcholine receptor 48 exon skipping 48 antisense compounds 48 nitric oxide donating prostaglandin 48 AVANIR Pharmaceuticals Inc. 48 tyrosine kinase inhibitor TKI 48 TELINTRA 48 proprietary dermal 48 peripherally acting 48 DNA gyrase 48 histone deacetylase HDAC inhibitor 48 metabolic enzymes 48 TLR agonists 48 OTCBB CHKT 48 inverse agonist 48 OTCBB CVBT 48 ophthalmology oncology 48 DXL TM antibodies 48 serine proteases 48 humanized monoclonal antibody 48 activate SIRT1 48 non nucleoside 48 dasatinib Sprycel 48 fibrotic diseases 48 Azedra 48 Response Genetics Inc. 48 GelSite R polymer 48 PRNewswire FirstCall Senomyx 48 pharmacogenomic tests 48 transmembrane proteins 48 NYSE Amex AEN 48 PDE7 48 antiviral cytokines 48 autologous cellular therapy 48 taxol 48 fatty acid amide hydrolase 48 XmAb# 48 Inc. Nasdaq IMMU 48 biomarker assays 48 personalized immunotherapy 48 CK # novel 48 PI3 Kinase 48 bioengineers novel 48 RNA interference RNAi therapeutics 48 Epeius Biotechnologies Corporation 48 liposomal 48 Inc. Nasdaq INFI 48 human antibody therapeutics 48 apoptotic pathway 48 NASDAQ EPIX 48 therapeutic mAbs 48 Novelos Therapeutics Inc. 48 novel topoisomerase 48 Panzem R 48 targeted antifolate 48 CD# monoclonal antibody 48 Ambrx 48 Nasdaq ENMD 48 PROLOR Biotech Inc. 48 intracellular protein 48 PPARγ 48 KinomeScan 48 BioWa 48 OTCBB TDLP 48 resolvin 48 selectively inhibits 48 Oxis International 48 belinostat 48 mucosal vaccines 48 NTDDS 48 tyrosine kinase inhibitor 48 membrane receptors 48 subtype selective 48 systemic RNAi therapeutic 48 vitamin D analogs 48 Nasdaq CRXL 48 D3 receptors 48 hypoxia inducible factor 48 Alvine Pharmaceuticals 48 Merrimack Pharmaceuticals 48 renin inhibitor 48 resolvins 48 Azixa 48 TÎ ² 4 48 PRNewswire FirstCall Aeterna Zentaris 48 nucleoside 48 immune stimulatory 48 antisense oligonucleotide 48 naturally occurring molecule 48 Sym# 48 ProNAi 48 renin inhibitors 48 Affimed Therapeutics AG 48 Cdc7 48 humanized antibody 48 Galenea 48 cardiovascular metabolic 48 thrombin receptor 48 TRACON Pharmaceuticals 48 TRV# [001] 48 CCR3 48 antibody fragment therapeutics 48 novel synthetic peptide 48 VIA Pharmaceuticals 48 sd rxRNA compounds 48 PLK1 SNALP 48 HDAC inhibition 48 beta secretase inhibitors 48 antagomirs 48 NovaBay Pharmaceuticals Inc. 48 drug conjugate 48 Akebia Therapeutics 48 Supernus Pharmaceuticals 48 Provectus Pharmaceuticals specializes 48 miRNA therapeutics 48 ApoB SNALP 48 inhibit viral replication 48 acetylcholinesterase AChE 48 Anidulafungin 48 myeloproliferative disorders 48 OTCBB NVLT biopharmaceutical 48 MP4 molecule 48 commercializes biotherapeutics 48 Survivin antagonist 48 Nasdaq IDRA today 48 Mersana Therapeutics 48 Cyclosert TM 48 4E BP1 48 Nasdaq OMER biopharmaceutical 48 Archemix Corp. 48 Smac mimetic 48 commercializing oxidized glutathione 48 Inc. OTCBB ECTE 48 CEQ# 48 receptor modulators 48 peptidic 48 biotherapeutic 48 imaging radiopharmaceuticals 48 effector functions 48 Hepatitis C Virus HCV 48 PRNewswire FirstCall YM BioSciences 48 Annamycin 48 CD# antibody [001] 48 ZFN TM 48 metabotropic glutamate receptor 48 Nasdaq DYAX 48 macrocycles 47 Myrexis Inc. 47 OXi# 47 albumin naturally occurring 47 San Diego Amira Pharmaceuticals 47 ALK inhibitor 47 Anticalins 47 immunomodulatory 47 OTCQB ABPI 47 targeted covalent 47 Onconase 47 Trophos 47 Nasdaq IMGN 47 alkylating 47 liposomal formulations 47 immunomodulator 47 Omeros Corporation 47 nucleoside analog 47 Promedior 47 Chemokine Receptor 47 TSX VENTURE GAP 47 cortisol synthesis 47 Ampakine compounds 47 Inc. OTCBB SNWV 47 siRNA conjugates 47 humanized monoclonal 47 EZN 47 cytotoxin 47 MEK1 47 ADVEXIN p# therapy 47 anticancer agent 47 acetonide FA 47 osteolytic bone disease 47 thymidylate synthase TS 47 Xytis 47 Gleevec resistant 47 methyl D aspartate 47 trans splicing 47 HuCAL antibody 47 HQK 47 Aviptadil 47 polysaccharide polymer 47 dermatological diseases 47 monoclonal 47 multitargeted 47 immunomodulating 47 ligands 47 RNA antagonists 47 GAP #B# 47 salmon calcitonin 47 biocatalysts 47 XSSE OXGN 47 Fx #A 47 ALN VSP 47 azoles 47 covalent drugs 47 WellCity proprietary 47 biobetter 47 PDGF receptor 47 immuno inflammatory diseases 47 HDAC inhibitors 47 neuropathic pain metabolic diseases 47 commercializing aptamer therapeutics 47 ALN TTR# 47 oxidative stress inducer 47 Omacetaxine 47 Avila Therapeutics 47 symbol AVXL 47 Genaera Corporation 47 rheumatoid arthritis psoriasis Crohn 47 immunotoxin 47 siRNA mediated 47 Oral NKTR 47 Antisense 47 thapsigargin 47 NASDAQ INGN 47 immunomodulators 47 Protalex Inc. 47 Inc. NASDAQ IDMI 47 peroxisome proliferator activated 47 Nasdaq MNKD focused 47 Nasdaq VRTX 47 TGR5 47 theranostics 47 PRT# 47 estrogen receptor beta 47 Aerie Pharmaceuticals 47 tranilast 47 carbohydrate polymers 47 Gemin X 47 vanilloid receptor 47 NovaBay Pharmaceuticals 47 Fero Industries Inc. 47 receptor partial agonist 47 receptor agonist 47 xenograft models 47 Janus Kinase 47 signal transduction inhibitor 47 Charlesson 47 NMDA N 47 NASDAQ ALTH biopharmaceutical 47 cathepsins 47 microtubule inhibitor 47 immunologic diseases 47 PI3K 47 chemokine 47 Metallophile ™ Technology 47 mAbs 47 Inc. NASDAQ AGIX 47 personalized cellular immunotherapy 47 systemic RNAi 47 SGLT2 47 Pathway Inhibitor 47 lead molecular radiotherapeutic 47 oral immunomodulatory 47 5alpha reductase 47 AVEO Pharmaceuticals Inc. 47 phosphoinositide 3 47 Intellikine 47 thromboxane A2 47 Friedreich Ataxia FRDA 47 Posiphen 47 telomerase activators 47 NYSE Amex RNN 47 3 kinase PI3K 47 Stapled Peptide 47 PARP inhibitor 47 FoldRx 47 α β 47 CNW Telbec Aeterna Zentaris 47 target enzyme thymidylate 47 companion diagnostics 47 proprietary phage display 47 HepDirect technology 47 Spiegelmers R 47 KRN# 47 BAY #-# 47 cardiac myosin 47 NASDAQ EMIS 47 RONDEL TM 47 PI3K/AKT 47 LentiVector technology 47 HGS# 47 protein biomarkers 47 sd rxRNA 47 PI3K AKT 47 Chemokine Therapeutics 47 protein tyrosine phosphatases 47 HSP# inhibitors 47 Prodarsan R 47 Affibody ® molecules 47 triphosphate 47 MET VEGFR2 47 Aganocide 47 NYSE Amex NBY clinical 47 PARP inhibitors 47 aurora kinase inhibitor 47 JAK inhibitors 47 Frankfurt XMP 47 Cynapsus Therapeutics Inc. 47 engineered RAP peptides 47 Akesis Pharmaceuticals 47 delivered RNAi therapeutic 47 PDE4 47 NR2B subunit 47 highly selective endothelin 47 CAMBRIDGE Mass. Alnylam Pharmaceuticals 47 stem cell therapeutics 47 tyrosine kinase inhibitors 47 integrin receptors 47 proliferative diseases 47 topical anti infective 47 aberrantly activated 47 coronary stent merged 47 antibody fragment 47 NASDAQ LGND